Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study
dc.contributor.author | Abali, Huseyin | |
dc.contributor.author | Celik, Ismail | |
dc.contributor.author | Karaca, Burcak | |
dc.contributor.author | Turna, Hande | |
dc.contributor.author | Saglam, Esra Kaytan | |
dc.contributor.author | Akman, Tuelay | |
dc.contributor.author | Oztop, Ilhan | |
dc.date.accessioned | 2024-04-24T17:33:26Z | |
dc.date.available | 2024-04-24T17:33:26Z | |
dc.date.issued | 2015 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Purpose: To develop a large Turkish National Melanoma registry in order to define demographic and clinicopathologic characteristics of patients with melanoma. Methods: The data was collected from 1635 patients with melanoma through a web-based registry system in 22 centers. Herein we present the results of 1157 patients with cutaneous melanoma. Results: The patient median age was 56.4 years and 646 (55.8%) were males. The commonest subtype was superficial spreading type (357, 30.9%). The commonest primary site was the lower extremities (N=353, 30.5%). The most common Breslow thickness was 1-2 mm (361 patients, 43.5%). Only 104 (12.5%) patients had a thickness <1mm. Among 694 patients with available data, 136 (19.6%) presented with stage 4 disease while the most frequent stage was stage 3, encountered in 393 (56.6% patients). Conclusion: Our melanoma registry is the largest in our country providing a snapshot view of cutaneous melanoma and its care. Our patients presented with more advanced stages and they had worse prognosis compared to SEER database. | en_US |
dc.description.sponsorship | Bristol Myers Squib | en_US |
dc.description.sponsorship | The authors declare that they received financial support from Bristol Myers Squib for data collection and statistical analyses. | en_US |
dc.identifier.endpage | 1141 | en_US |
dc.identifier.issn | 1107-0625 | |
dc.identifier.issn | 2241-6293 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 26416068 | |
dc.identifier.scopus | 2-s2.0-84943233086 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 1137 | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/20686 | |
dc.identifier.volume | 20 | en_US |
dc.identifier.wos | WOS:000361421900028 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Imprimatur Publications | en_US |
dc.relation.ispartof | Journal of Buon | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Clinical Features | en_US |
dc.subject | Cutaneous Melanoma | en_US |
dc.subject | Pathology | en_US |
dc.subject | Registry | en_US |
dc.subject | Staging | en_US |
dc.subject | Turkey | en_US |
dc.title | Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study | en_US |
dc.title | Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study | |
dc.type | Article | en_US |